Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
70%
Neoplasm
39%
Fluorodeoxyglucose F 18
38%
Positron Emission Tomography
37%
Fluorine-18
35%
Nuclear Medicine
29%
Posttransplant Lymphoproliferative Disease
24%
Radioactive Tracer
23%
Biological Marker
22%
Radiology
21%
Amyloidosis
20%
Image Quality
20%
Prostate Cancer
19%
Neuroendocrine Tumor
18%
DOPA
17%
Sympathetic Innervation
17%
Diagnosis
16%
Iodine 123
15%
Head and Neck Cancer
15%
Radiation Therapy
15%
Single-Photon Emission Computed Tomography
14%
Esophageal Cancer
13%
Molecular Imaging
12%
Disease
12%
Xerostomia
12%
Radiomics
11%
Lutetium 177
11%
Recurrent Disease
11%
(3 Iodobenzyl)guanidine
10%
Chemoradiotherapy
10%
Prostate Specific Membrane Antigen
10%
Computer Assisted Tomography
10%
Carbon 11
10%
Dosimetry
10%
Heart Amyloidosis
10%
Single Photon Emission Computed Tomography-Computed Tomography
9%
Nuclear Medicine Physician
9%
Tetraxetan
9%
ATTR Amyloidosis
8%
Metastatic Carcinoma
8%
Scintigraphy
8%
Necrosis
8%
Denervation
8%
Standardized Uptake Value
7%
Echocardiography
7%
Radioisotope
7%
Gallium 68
7%
Bone Scintigraphy
7%
Amyloid
7%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
24%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
24%
Cardiac Sympathetic Denervation
14%
Long Axial Field of View PET
13%
Single-photon Emission Computed Tomography (SPECT)
13%
Whole-body
12%
Nuclear Medicine
10%
Post-transplant Lymphoproliferative Disorder
10%
18F-FDG PET-CT
10%
Digital Biomarkers
10%
Patlak
10%
Input Function
9%
Population-averaged
9%
Nuclear Imaging
8%
Biograph Vision Quadra
7%
F-18
7%
18F-fluorodeoxyglucose (18F-FDG)
7%
Molecular Imaging
6%
Radiology Residency
6%
Nuclear Radiology
6%
Netherlands
6%
Residency Program
6%
PET Image
6%
Prostate-specific Antigen
6%
Radiation-induced Xerostomia
6%
Xerostomia
6%
123I-MIBG
5%
Tumor
5%
18F-fluorodeoxyglucose PET
5%
PSMA PET-CT
5%
Tracer Uptake
5%
Positron Emission Tomography
5%